In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives As Potential Anti-Alzheimer Agents. Int J Med Sci H Care Res Inn 2026, 1 (2), 16-39.